Impel Pharmaceuticals (IMPL) Institutional Ownership

Notice: This company has been marked as potentially delisted and may not be actively trading.

Institutional Ownership Changes (13F Filings) for Impel Pharmaceuticals (NASDAQ:IMPL)

Current
Institutional Ownership
Percentage
73.88%
Number of
Institutional Buyers
(last 12 months)
1
Total
Institutional Inflows
(last 12 months)
$10.80K
Number of
Institutional Sellers
(last 12 months)
2
Total
Institutional Outflows
(last 12 months)
$179.48K
Get IMPL Insider Trade Alerts

Want to know when executives and insiders are buying or selling Impel Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

IMPL Institutional Buying and Selling by Quarter

Impel Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/15/2023Lasry Marc225,874$97K0.1%-44.7%0.951%
8/9/2023DCF Advisers LLC303,605$386K0.2%-20.8%1.278%
7/17/2023Mcdonald Partners LLC20,200$26K0.0%+72.6%0.085%
1/18/2023Mcdonald Partners LLC11,700$44K0.0%N/A0.049%
11/14/2022Ergoteles LLC24,447$119K0.0%-13.9%0.103%
8/15/2022Opaleye Management Inc.144,642$1.35M0.6%N/A0.624%
8/15/2022Laurion Capital Management LP124,800$1.16M0.0%N/A0.539%
8/11/2022DCF Advisers LLC438,566$4.09M2.4%+19.5%1.893%
5/9/2022Qube Research & Technologies Ltd11,867$76K0.0%-41.7%0.051%
2/14/2022Point72 Hong Kong Ltd5,864$51K0.0%N/A0.025%
2/14/2022Point72 Asset Management L.P.208,760$1.80M0.0%N/A0.906%
2/10/2022Qube Research & Technologies Ltd20,342$176K0.0%N/A0.088%
2/9/2022Alps Advisors Inc.26,662$230K0.0%N/A0.116%
2/3/2022Brighton Jones LLC14,145$122K0.0%N/A0.061%
2/1/2022Qube Research & Technologies Ltd20,342$176K0.0%N/A0.088%
1/28/2022Allspring Global Investments Holdings LLC26,675$230K0.0%N/A0.116%
1/25/2022Epiq Partners LLC18,646$161K0.1%N/A0.081%
12/10/2021Towercrest Capital Management50,500$615K0.1%N/A0.219%
11/15/2021First Manhattan Co.6,700$81K0.0%N/A0.034%
11/12/2021Geode Capital Management LLC117,916$1.44M0.0%+131.5%0.604%
11/9/2021BlackRock Inc.268,730$3.27M0.0%+7.0%1.377%
11/8/2021Trustcore Financial Services LLC13,407$163K0.0%N/A0.069%
11/8/2021Russell Investments Group Ltd.200,806$2.45M0.0%N/A1.029%
11/2/2021New York State Common Retirement Fund6,867$84K0.0%-49.9%0.035%
11/2/2021Victory Capital Management Inc.80,390$979K0.0%-28.7%0.412%
10/13/2021FNY Investment Advisers LLC5,377$65K0.0%N/A0.028%
8/17/2021Woodline Partners LP119,615$1.06M0.0%N/A0.537%
8/17/2021Zimmer Partners LP25,000$221K0.0%N/A0.112%
8/17/2021Kohlberg Kravis Roberts & Co. L.P.3,802,639$33.65M0.1%N/A17.071%
8/16/20215AM Venture Management LLC2,884,791$25.53M6.4%N/A12.950%
8/16/2021California State Teachers Retirement System7,464$66K0.0%N/A0.034%
8/16/2021venBio Partners LLC2,759,791$24.42M2.9%N/A12.389%
8/16/2021Pinz Capital Management LP6,188$55K0.0%N/A0.028%
8/16/2021Charles Schwab Investment Management Inc.11,413$102K0.0%N/A0.051%
8/16/2021State Street Corp46,298$410K0.0%N/A0.208%
8/13/2021Northern Trust Corp58,493$518K0.0%N/A0.263%
8/13/2021Geode Capital Management LLC50,942$450K0.0%N/A0.229%
8/13/2021Vanguard Group Inc.183,753$1.63M0.0%N/A0.825%
8/12/2021JPMorgan Chase & Co.6,653$59K0.0%N/A0.030%
8/11/2021BlackRock Inc.251,063$2.22M0.0%N/A1.127%
Global crypto currency reset (41 major banks signed up) (Ad)

Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project...

 Here's everything you need to know.
8/11/2021Deutsche Bank AG3,196$28K0.0%N/A0.014%
8/10/2021Norwest Venture Partners Xiv LP3,077,198$27.23M31.4%N/A13.814%
8/3/2021Victory Capital Management Inc.112,730$998K0.0%N/A0.506%
(Data available from 1/1/2016 forward)

IMPL Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of IMPL shares?

During the previous two years, the following institutional investors and hedge funds held shares of Impel Pharmaceuticals shares: Opaleye Management Inc. ($1.35M), Laurion Capital Management LP ($1.16M), DCF Advisers LLC ($386K), Ergoteles LLC ($119K), Lasry Marc ($97K), and Qube Research & Technologies Ltd ($76K), and Mcdonald Partners LLC ($26K).Learn more on IMPL's institutional investors.

What percentage of Impel Pharmaceuticals stock is owned by institutional investors?

73.88% of Impel Pharmaceuticals stock is owned by institutional investors. Learn more on IMPL's institutional investor holdings.

Which institutional investors have been buying Impel Pharmaceuticals stock?

The following institutional investors have purchased Impel Pharmaceuticals stock in the last 24 months: Opaleye Management Inc. ($144.64K), Laurion Capital Management LP ($124.80K), DCF Advisers LLC ($71.51K), and Mcdonald Partners LLC ($20.20K).

How much institutional buying is happening at Impel Pharmaceuticals?

Institutional investors have bought a total of 361,150 shares in the last 24 months. This purchase volume represents approximately $3.23M in transactions.

Which Impel Pharmaceuticals major shareholders have been selling company stock?

The following institutional investors have sold Impel Pharmaceuticals stock in the last 24 months: Lasry Marc ($182.46K), DCF Advisers LLC ($79.54K), Qube Research & Technologies Ltd ($8.48K), and Ergoteles LLC ($3.95K).

How much institutional selling is happening at Impel Pharmaceuticals?

Institutional investors have sold a total of 274,426 shares in the last 24 months. This volume of shares sold represents approximately $252.71K in transactions.


This page (NASDAQ:IMPL) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners